Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City

Clinical and Experimental Rheumatology

Volumn 19, Issue 4, 2001, Pages 395-401

  Hernandez Cruz B ^a   Tapia, N ^a   Villa Romero, A R ^a   Reyes, E ^a   Cardiel, M H ^a  

^a Inst Nacl de Ciencias Med/Nutri   (Mexico)

Author keywords

Autopsy study; Disease activity; Mortality; Systemic lupus erythematosus

Indexed keywords

CHLOROQUINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; HEART DISEASE; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MEXICO; MORTALITY; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; SKIN DISEASE; STEROID THERAPY; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEXICO; MIDDLE AGED; PALLIATIVE CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0034927404     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Prognosis in systemic lupus erythematosus
2. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years
3. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases
4. Long-term survival in systemic lupus erythematosus. Patients characteristics associated with poorer outcomes
5. Mortality studies in systemic lupus erythematosus. Results from a single center II. Predictor variables for mortality
6. Prognosis and treatment of systemic lupus erythematosus
7. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients
8. Survival of Chilean patients with systemic lupus erythematosus
9. Mortality in systemic lupus erythematosus
10. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus
11. Mortality of Jamaican patients with systemic lupus erythematosus
12. Indicators of disease activity, prognosis and treatment of systemic lupus erythematosus
13. High mortality with systemic lupus erythematosus in hospitalized African blacks
14. A multicenter study of outcome in systemic lupus erythematosus. I Entry variables as predictors of prognosis
15. Systemic lupus erythematosus. Clinical features
16. The revised criteria for the classification of systemic lupus erythematosus
17. Antiphospholipid antibodies and antiphospholipid syndrome in systemic lupus erythematosus
18. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices
19. A simple severity disease index for systemic lupus erythematosus
20. College of American Pathologist Autopsy Committee: Basic autopsy technique
21. Systemic lupus erythematosus in Singapore
22. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival and outcome
23. Pulmonary hemorrhage in systemic lupus erythematosus
24. Pulmonary hypertension in systemic lupus erythematosus
25. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity
26. Lymphopenia in systemic lupus erythematosus
27. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
28. Remission of systemic lupus erythematosus
29. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
30. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort
31. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis
32. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death
33. Validity of retrospective disease activity assessment in systemic lupus erythematosus